Does The Data Supplment Teva Pharmaceutical Industries Limited (NYSE:TEVA) Movement?

12

Teva Pharmaceutical Industries Limited (NYSE:TEVA) closed its last session at $19.33. The stock traded within a range of $18.35 and $19.48. The company operates in the Healthcare sector with a market capitalization of 20.08 Million. Trading volume for Teva Pharmaceutical Industries Limited was 16.21 Million in its previous trading session. Currently, Teva Pharmaceutical Industries Limited (NYSE:TEVA) has an average volume of 23.38 Million.

Company Profile

TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals.  Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies.  The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions.  Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.

Analyst Views

Teva Pharmaceutical Industries Limited (NYSE:TEVA) received a Buy rating from 0 analysts. 0 analysts gave its stock an Outperform rating. 9 analysts say it’s a Hold while 0 analysts provided their expert opinion as Sell.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) touched its 1-Year High price of $37.94 on 02/21/17 and its 1-Year Low price of $10.85 on 11/02/17.

EPS & Financials

Teva Pharmaceutical Industries Limited (NYSE:TEVA) reported its EPS in the last quarter as $0.93/Share beating the analyst estimate of $0.76/Share by a difference of $0.17. This showed a surprise of 22.4% in the last quarter earnings.

For the current quarter, 21 analysts are projecting a mean EPS of $0.67/share. According to their observations and findings, the stock could provide a high EPS of $0.75/share and a low EPS of $0.53/share.

Analysts believe that the company has the potential to earn average revenue of $4.82 Billion for the current quarter. According to their predictions high & low revenue estimates are 4.96 Billion and 4.61 Billion respectively.

Technical Analysis

By taking a look at the stock’s current statistics it can gauged that the stock candle is BULLISH with MEDIUM volatility. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has a 20-Day average volume of 18.09 Million. According to today’s trading volume Teva Pharmaceutical Industries Limited is BELOW its 20-Day Avg. volume with the stock showing BELOW Abnormal volume in the past 150 days.

Moving average convergence divergence (MACD) shows that the stock is on a PRICE RELATIVITY trend. The trend for the past 10-days shows that the company was in BEARISH territory while an analysis of the last 40-Day trend shows a BULLISH signal. The 100-Day trend also shows a BULLISH trend as well.

The company currently has an insider ownership of 2.7 Percent and Institutional ownership of 56.7 Percent. The return on assets stands at -19.8%, Return on Equity currently is -68% and the Return on Investment value is -31.2%.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) gross margin percentage stands at 49.8% while its operating margin for the past trailing twelve month is -74.7 percent and its overall profit margin (ttm) is -70.6 Percent. The stock is currently moving below its 20-Day Simple Moving Average of -5.33% with a 50-Day Simple Moving Average of 1.57 percent. As of today, the company has a SMA200 (200-day simple moving average) of -10.55 Percent. The Stock has YTD (year to date) performance of 2.01 percent.

The TTM operating margin for the company stands at -74.7%. The return on invested capital is at -31.2%, which is good, compared to its peers. The Free Cash Flow or FCF margin is 0.

The company’s stock is currently moving with a -ve distance from the 200 day SMA of approximately -10.55%, and has a solid year to date (YTD) performance of 2.01% which means that the stock is constantly adding to its value from the previous fiscal year end price.